REGN
Regeneron Pharmaceuticals Inc
Price:  
1,036.52 
USD
Volume:  
353,226.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron WACC - Weighted Average Cost of Capital

The WACC of Regeneron Pharmaceuticals Inc (REGN) is 8.0%.

The Cost of Equity of Regeneron Pharmaceuticals Inc (REGN) is 8.05%.
The Cost of Debt of Regeneron Pharmaceuticals Inc (REGN) is 4.30%.

Range Selected
Cost of equity 7.10% - 9.00% 8.05%
Tax rate 9.50% - 11.60% 10.55%
Cost of debt 4.00% - 4.60% 4.30%
WACC 7.0% - 8.9% 8.0%
WACC

Regeneron WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.7 0.74
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 9.00%
Tax rate 9.50% 11.60%
Debt/Equity ratio 0.02 0.02
Cost of debt 4.00% 4.60%
After-tax WACC 7.0% 8.9%
Selected WACC 8.0%